SCHEMBL13725911

SCHEMBL13725911

N[C@@H](CC(Cc1ccc(O)cc1)C(=O)O)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 4/20 0.75
SLC1A3 P43003 2/20 0.75
SLC1A2 P43004 2/20 0.75
SLC7A5 Q01650 3/20 0.71
GRM2 Q14416 1/20 0.51
GRM3 Q14832 1/20 0.51
PTGS1 P23219 2/20 0.50
GRIK1 P39086 1/20 0.50
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
XIAP P98170 1/20 0.50
ANPEP P15144 2/20 0.49
ERAP2 Q6P179 2/20 0.49
ERAP1 Q9NZ08 2/20 0.49
LAP3 P28838 1/20 0.49
ENPEP Q07075 1/20 0.49
CYP1A2 P05177 1/20 0.48
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
EGFR P00533 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819024 1.00 SLC1A1 (0.75) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL13725557 1.00 SLC1A1 (0.75) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL2265548 0.86 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL130817 0.86 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL8377822 0.86 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL133913 0.86 SLC1A1 (1.00) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL2263860 0.85 SLC1A3 (0.73) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL14681209 0.85 SLC1A1 (0.73) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL8384161 0.85 SLC1A1 (0.73) SLC1A1SLC1A3SLC1A2SLC7A5GRM2
SCHEMBL1819970 0.85 SLC1A1 (0.73) SLC1A1SLC1A3SLC1A2SLC7A5GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9238631-B2 Radiolabeled amino acids for diagnostic imaging PIRAMAL IMAGING SA (CH) 2016-01-19 US disclosed
US-20150011773-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING PIRAMAL IMAGING SA (CH) 2015-01-08 US disclosed
EP-2705012-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING Piramal Imaging SA (CH) 2014-03-12 EP disclosed
WO-2012150220-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011773-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING SLC1A5, SLC6A19, BCAT2 SLC1A1 15/4885SLC1A3 11/4885SLC1A2 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.